Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-06

Clinical Trial Update: Pilot Study to Collect and Evaluate Data on the Use of IV* Ibuprofen in the Treatment of an Acute Migraine Attack [Phase 4]

View source ↗

Summary

Phase 4 pilot study evaluating IV ibuprofen for acute migraine; study completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IV Ibuprofen (ibuprofen)

Snippet

Sponsor: Thomas Jefferson University | Conditions: Episodic Migraine | Phase 4 | Status: COMPLETED | Results posted: 2022-09-06